WednesdaySep 27, 2023 11:43 am

How to Maximize ROI from an eCommerce Advertising Budget

With Americans spending hundreds of billions of dollars on online purchases every year, e-commerce is one of the largest platforms for trade in the country. It allows companies to significantly broaden their potential customer base and provides varied and affordable means of marketing and advertising. With an estimated 2.5 million online retailers in the United States alone and 9.1 million on the entire globe, a proper marketing and advertising strategy will be key to attracting a sufficient customer base and building a respectable brand. Maximizing ROI on advertising will allow you to bring in as much value as possible from…

Continue Reading

WednesdaySep 27, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Eyeing Global HLHS, in addition to Alzheimer’s Disease, and Aging-Related Frailty Treatment Markets with Lomecel-B(TM), its Lead Investigational Product

Longeveron’s study ELPIS I demonstrated 100% survival and heart transplant-free for up to 5 years of age All ten patients enrolled in the study were monitored for at least 3.5 years after treatment with Lomecel-B(TM), the company’s lead investigational product Longeveron’s study results show Lomecel-B(TM)’s potential, not just for the potential treatment of HLHS but also for Alzheimer’s disease and Aging-related Frailty Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions, recently posted promising results from its ELPIS I clinical trial. Of note was data that showed that 100% of the ten patients who…

Continue Reading

TuesdaySep 26, 2023 2:33 pm

Surgical Robot Prototype Could Ease Pediatric Brain Cancer Surgery

Researchers from Boston Children’s Hospital say they have created a prototype surgical tool that can allow surgeons to remove pediatric brain tumors safely and in a less invasive manner.  The surgical robot uses hollow, nitinol robot arms to give surgeons the ability to switch tools during tumor resections and could also have applications for neurosurgery in adults and other surgical procedures. Study coauthor and Boston Children’s Hospital chief of pediatric cardiac bioengineering Pierre DuPont said the idea for the project goes back to 2016 when he had conversations with Dr. Jim Drake, the chief of neurosurgery at Toronto-based SickKids. DuPont…

Continue Reading

TuesdaySep 26, 2023 9:00 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Looking to Capitalize on UPNEEQ’s Significant Potential

UPNEEQ(R) is the first FDA-approved non-surgical treatment option for acquired blepharoptosis (ptosis), or low-lying eyelid Clinical studies have shown an average one-millimeter lift of the upper eyelid, with results in as little as five minutes post-dose UPNEEQ(R) is available through RVL Pharmaceuticals’ dedicated e-commerce platform, Elevate, which supports subscription ordering by HCPs and RVL Pharmacy patients RVL is poised to be an integral player in the global medical aesthetic market, which is estimated to reach $18 billion by 2027 RVL Pharmaceuticals (NASDAQ: RVLP), is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for…

Continue Reading

MondaySep 25, 2023 1:17 pm

Inverse Vaccines Show Promise Against Autoimmunity

University of Chicago Pritzker School of Molecular Engineering (PME) researchers have developed a new vaccine that has completely reversed autoimmune disorders in laboratory settings. This “inverse vaccine” works by wiping out the immune system’s memory of a perceived irritant rather than suppressing the immune system to limit autoimmunity symptoms. The immune system is essentially a battle-ready system of defenses ready to attack and destroy any threats at the drop of a hat. In some people, the immune system is overly sensitive and will react aggressively after mistaking harmless substances such as proteins, pollen and healthy tissues, for threats. This results…

Continue Reading

MondaySep 25, 2023 10:30 am

Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study

CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer CNS has enrolled 200 of its planned 243 patients for its clinical trial roster, and anticipates filling out the remainder of patients by year’s end The company is also preparing the interim study analysis for release by year’s end, now that more than 50 percent of the planned patient roster has reached a point necessary for effective comparison of performance of the flagship drug, Berubicin, to that of a standard of care chemotherapy agent The company has stated that…

Continue Reading

FridaySep 22, 2023 12:29 pm

Why Colon Cancer Is Largely Unresponsive to Immunotherapy

Colorectal cancer is the third-most common type of cancer among adults in the United States, affecting an estimated 106,970 people in 2023 and predicted to take more than 50,000 lives this year. Treatment often involves surgery to remove as much of the tumor as possible, followed by chemotherapy and radiation therapy to kill off any remaining tumor cells. Recent research published in the “Nature Genetics” journal has shed new light on why immunotherapy, a relatively new type of cancer treatment that uses a patient’s own immune system to kill cancer cells, isn’t as effective against colon cancers. Researchers studied the…

Continue Reading

ThursdaySep 21, 2023 12:14 pm

Five Ways to Prep Your eCommerce Site for Success

E-commerce accounted for close to 19% of global retail sales in 2022 and was projected to reach a valuation of $5.5 trillion in sales by the end of the year. With tens of millions of e-commerce businesses competing to attract the billions of customers who purchase products online every year, you will need an inspired strategy to stand out from the pack and build an identifiable brand. Lessons learned from this year should inform your decision-making process as you move into 2024. Review data from this year’s campaigns and reports to see if you can glean any insights or spot…

Continue Reading

WednesdaySep 20, 2023 12:06 pm

Nottingham University Researchers Find Way to Make Brain Cancer Cells Self-Destruct

Nottingham University researchers have devised a novel means of treating brain cancer that could signal a “quantum leap” in brain-tumor treatments moving forward.  A multidisciplinary research team created a new way of targeting and eliminating cancer cells in typically hard-to-treat types of brain tumors that cause cancer cells to essentially self-destruct. This technique involves leveraging bio-nanoantenna, extremely tiny gold particles (nanoparticles) coated with redox active molecules that are specialized to bring about programmed cell death (apoptosis). Upon electrical stimulation, bio-nanoantenna can induce the self-destruction of brain tumor cells, giving physicians a potential treatment option with much higher chances of better…

Continue Reading

WednesdaySep 20, 2023 11:15 am

Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources

California-based cancer fighter Renovaro BioSciences is turning the power of its immune system-promoting technology to the fight against pancreatic cancer and other illnesses that tend to leave patients with a short life expectancy once they are diagnosed Renovaro recently announced a binding, exclusive letter of intent (“LOI”) to add GEDI Cube’s artificial intelligence (“AI”) data mining technology to its fight against such cancers GEDI Cube is strengthening its platform’s potential by joining with the NVIDIA Inception program, which nurtures start-ups by providing access to cutting-edge technology, technical resources, and venture capitalists The companies hope to detect pancreatic tumors at early…

Continue Reading

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050